Philipp Haselmayer

1.1k total citations
18 papers, 847 citations indexed

About

Philipp Haselmayer is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Philipp Haselmayer has authored 18 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Philipp Haselmayer's work include Chronic Lymphocytic Leukemia Research (6 papers), Immune Response and Inflammation (5 papers) and Systemic Lupus Erythematosus Research (4 papers). Philipp Haselmayer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Immune Response and Inflammation (5 papers) and Systemic Lupus Erythematosus Research (4 papers). Philipp Haselmayer collaborates with scholars based in Germany, United States and Switzerland. Philipp Haselmayer's co-authors include Markus P. Radsak, Hansjörg Schild, Philipp von Landenberg, Ludger Große‐Hovest, Roland Grenningloh, Andrew T. Bender, Federica Morandi, Jared Head, Lesley Liu‐Bujalski and Theresa Johnson and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Philipp Haselmayer

18 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Haselmayer Germany 13 482 220 207 152 120 18 847
P. Brent Ferrell United States 17 341 0.7× 325 1.5× 126 0.6× 296 1.9× 179 1.5× 49 1.1k
Jesús Villarrubia Spain 15 520 1.1× 158 0.7× 132 0.6× 182 1.2× 96 0.8× 45 1.0k
Lino L. Teichmann Germany 10 675 1.4× 216 1.0× 106 0.5× 185 1.2× 38 0.3× 26 1.2k
Shruti Sharma United States 14 654 1.4× 411 1.9× 104 0.5× 121 0.8× 31 0.3× 20 1.1k
Minh Diem Vu United States 17 848 1.8× 261 1.2× 126 0.6× 100 0.7× 71 0.6× 26 1.4k
Masato Yagita Japan 17 618 1.3× 243 1.1× 74 0.4× 188 1.2× 181 1.5× 52 1.1k
Hélène Jouault France 16 191 0.4× 240 1.1× 259 1.3× 369 2.4× 88 0.7× 33 801
Felice Rivellese United Kingdom 21 713 1.5× 245 1.1× 78 0.4× 109 0.7× 114 0.9× 54 1.4k
Annick Tibi France 15 289 0.6× 328 1.5× 153 0.7× 136 0.9× 45 0.4× 32 951
Mitsuhiro Iwahashi Japan 12 449 0.9× 153 0.7× 94 0.5× 238 1.6× 43 0.4× 18 914

Countries citing papers authored by Philipp Haselmayer

Since Specialization
Citations

This map shows the geographic impact of Philipp Haselmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Haselmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Haselmayer more than expected).

Fields of papers citing papers by Philipp Haselmayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Haselmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Haselmayer. The network helps show where Philipp Haselmayer may publish in the future.

Co-authorship network of co-authors of Philipp Haselmayer

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Haselmayer. A scholar is included among the top collaborators of Philipp Haselmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Haselmayer. Philipp Haselmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Torke, Sebastian, Darius Häusler, Philipp Haselmayer, et al.. (2020). Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease. Acta Neuropathologica. 140(4). 535–548. 70 indexed citations
2.
Vlach, Jaromir, Andrew T. Bender, Melinda Przetak, et al.. (2020). Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity. Journal of Pharmacology and Experimental Therapeutics. 376(3). 397–409. 50 indexed citations
3.
Sherer, Brian, Andrew T. Bender, Albertina Pereira, et al.. (2020). O37 M5049, a novel potent and selective inhibitor of toll-like receptors 7 and 8 (TLR 7/8). Oral Presentations. A28.2–A28. 4 indexed citations
4.
Hatz, Sonja, Scott Spangler, Andrew T. Bender, et al.. (2019). Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson. PLoS ONE. 14(4). e0214619–e0214619. 8 indexed citations
5.
Grenningloh, Roland, et al.. (2019). 216 Inhibition of brutons tyrosine kinase (BTK) prevents inflammatory macrophage differentiation: a potential role in SLE. Abstracts. A161–A162. 4 indexed citations
6.
Haselmayer, Philipp, Montserrat Camps, Lesley Liu‐Bujalski, et al.. (2019). Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models. The Journal of Immunology. 202(10). 2888–2906. 108 indexed citations
7.
Aqrawi, Lara A., A. Björk, Juliana Imgenberg‐Kreuz, et al.. (2018). Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing. Clinical & Experimental Immunology. 192(3). 259–270. 19 indexed citations
8.
Bender, Andrew T., A.S. Gardberg, Albertina Pereira, et al.. (2017). Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling. Molecular Pharmacology. 91(3). 208–219. 126 indexed citations
9.
Haselmayer, Philipp, Michele Vigolo, Josquin Nys, Pascal Schneider, & Henry Hess. (2017). A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. European Journal of Immunology. 47(6). 1075–1085. 22 indexed citations
10.
Haselmayer, Philipp, Michele Vigolo, Josquin Nys, Pascal Schneider, & Henry Hess. (2016). THU0245 Individual versus Combined BLYs Or/and april Neutralization Reveals Developmental Plasticity for Plasma Cell Survival Factor Requirements. Annals of the Rheumatic Diseases. 75. 276–277. 1 indexed citations
11.
Haselmayer, Philipp, Montserrat Camps, Lesley Liu‐Bujalski, et al.. (2016). THU0275 Pharmacodynamic Modeling of BTK Occupancy versus Efficacy in RA and SLE Models Using The Novel Specific BTK Inhibitor M2951. Annals of the Rheumatic Diseases. 75. 286–287. 3 indexed citations
12.
Haselmayer, Philipp, Montserrat Camps, Samer El Bawab, et al.. (2014). Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies. Frontiers in Immunology. 5. 233–233. 24 indexed citations
13.
Haselmayer, Philipp, I. Scharrer, Markus Munder, et al.. (2012). A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome. PLoS ONE. 7(7). e42176–e42176. 34 indexed citations
14.
Haselmayer, Philipp, Christine Tertilt, Helmut R. Salih, et al.. (2009). Signaling Pathways of the TREM-1- and TLR4-Mediated Neutrophil Oxidative Burst. Journal of Innate Immunity. 1(6). 582–591. 32 indexed citations
15.
Radsak, Markus P., Christian Taube, Philipp Haselmayer, et al.. (2007). Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease. SHILAP Revista de lepidopterología. 2007. 1–7. 52 indexed citations
16.
Haselmayer, Philipp, Ludger Große‐Hovest, Philipp von Landenberg, Hansjörg Schild, & Markus P. Radsak. (2007). TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 110(3). 1029–1035. 176 indexed citations
17.
Haselmayer, Philipp, Stefan Tenzer, Byoung S. Kwon, et al.. (2006). Herpes virus entry mediator synergizes with Toll‐like receptor mediated neutrophil inflammatory responses. Immunology. 119(3). 404–411. 12 indexed citations
18.
Warger, Tobias, Gerd Rechtsteiner, Philipp Haselmayer, et al.. (2006). Interaction of TLR2 and TLR4 Ligands with the N-terminal Domain of Gp96 Amplifies Innate and Adaptive Immune Responses. Journal of Biological Chemistry. 281(32). 22545–22553. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Brent Ferrell Breakdown of academic impact, for papers by Jesús Villarrubia Breakdown of academic impact, for papers by Lino L. Teichmann Breakdown of academic impact, for papers by Shruti Sharma Breakdown of academic impact, for papers by Minh Diem Vu Breakdown of academic impact, for papers by Masato Yagita Breakdown of academic impact, for papers by Hélène Jouault Breakdown of academic impact, for papers by Felice Rivellese Breakdown of academic impact, for papers by Annick Tibi Breakdown of academic impact, for papers by Mitsuhiro Iwahashi
Rankless by CCL
2026